The Stem Cell Research Newswire: Comprehensive Real-Time News Feed for Stem Cell Research
Friday, August 1, 2014
Seattle Genetics Reports Second Quarter 2014 Financial Results
The company also highlighted ADCETRIS commercialization and clinical development accomplishments, progress with its antibody-drug conjugate pipeline, collaborator updates and upcoming activities.
No comments:
Post a Comment